Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA) (OCAPA)

14 de diciembre de 2020 actualizado por: University Hospital, Clermont-Ferrand

Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients

Following preliminary studies carried out in our department on these subject and subjective findings during clinical examinations, it has been shown that pain is a symptom that is rarely reported following treatment. Instead, neurosensory disorders such as hypoesthesia and paresthesia are found.

The objective of the study is to map and qualitatively evaluate neurosensory disorders in patients treated for cancers of the oral cavity and oropharynx.

Descripción general del estudio

Descripción detallada

The protocol, which is done during the usual follow-up consultation of the patient by the maxillo-facial surgeon, is divided into 3 parts:

PART 1: Collection of Data and Consent

  • Patient Data:

    • Date of visit and inclusion in the study
    • Patient initials
    • Age
    • Gender (male or female)
    • The weight
    • The size
  • Verification of inclusion and non-inclusion criteria:
  • General patient history:

    • Patient history
    • Ongoing Treatments
    • Professional activity
  • Tumor:

    • Features
    • Location
    • TNM
    • Histological type
  • Search for risk factors for peripheral neuropathy
  • Check for symptoms of peripheral neuropathy.

PART 2: Collecting Treatment Data

  • Operating data:

    • Operation date
    • Type of surgery
    • Duration of surgery
    • Severed sensory nerves
    • Perioperative complications
  • On the way out:

    • Adjuvant treatment including radiotherapy and/or chemotherapy.
    • Exit analgesic treatment
    • EN (Numerical Scale)

PART 3: Collection of data related to neurosensory disorders and pain

  • Analgesics consumed
  • Questionnaire DN4 for each operated area separated according to the curage, lumpectomy and reconstruction if they take place.
  • If DN4 positive, completion of the QCD and QEDN questionnaires.
  • Clinical examination for sensory disturbances reported on a chart.
  • Generic quality of life questionnaire adapted to cancer pathology EORTC QLQC30 and its specific Head and Neck35 add-on module adapted to head and neck cancers.
  • Thermotest and hot water, cold water (for the oral cavity)
  • HADS Questionnaire
  • Catastrophe Questionnaire
  • Quantitative sensory testing (QST) for neuropathic patients :

Mechanical neurosensory disorders will be tested with the Von frey filament and the brush.

  • Hypoesthesia or mechanical anaesthesia will be sought with the Von Frey filament and the brush.
  • Mechanical hypersensitivity, a painful sensation exacerbated by a sharp, non-traumatic object, will be sought with a large calibre Von Frey filament.
  • Static Allodynia, felt painful on contact, will be sought at Von Frey's filament.
  • Dynamic Allodynia, felt painful when rubbed, will be sought with a wide brush (8 mm) over a distance of several centimetres.

Thermal neurosensory disorders will be sought for the skin with the Thermotest and at the level of the oral cavity with the application of standardised test tubes containing water at 4°C stored in the fridge or hot water at 63°C (the protocol consists of heating water at 4°C in the microwave for 30 seconds to obtain the temperature of 63°C); these examinations will allow the evaluation of thermal allodynia and hypoesthesia.

The examination will cover the entire face, the oral cavity, the cervical region and the area where the reconstruction flaps are taken. The pathological areas identified will be delimited on diagrams previously made with a coding according to the sensations collected.

Tipo de estudio

Intervencionista

Inscripción (Anticipado)

120

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Clermont-Ferrand, Francia, 63000
        • Reclutamiento
        • CHU de Clermont-Ferrand
        • Contacto:
        • Investigador principal:
          • Nathalie PHAM DANG
        • Sub-Investigador:
          • Laurent DEVOIZE

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Patient treated for an oral cavity and oropharynx tumor from at least one year and maximum five years.
  • Women or men upper 18 years old)
  • Patient with full consent, aware and signed
  • Patient cover by the French social security system

Exclusion Criteria:

  • Patient with mental disorder, psychologic, with a defect of comprehension to agree fully the protocol
  • Pregnant women or nursing
  • Patients who can't comply with the protocol
  • Participation refusal
  • Inable full age patient or under judicial protection

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Diagnóstico
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: patient treated for a oral cavity and oropharynx cancer
questionnaire and tests to evaluate neuropathic pain
Thermotest and hot water, cold water (for the oral cavity), Von frey filament and the brush

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
hypoesthesia on surgical site using a brush and Von Frey Filament
Periodo de tiempo: day 0
The measure is a binary measure (positive or negative)
day 0
anaesthesia on surgical site using a brush and Von Frey Filament
Periodo de tiempo: day 0
The measure is a binary measure (positive or negative)
day 0
allodynia on surgical site
Periodo de tiempo: day 0
The measure is a binary measure (positive or negative) by clinical examination
day 0
Evaluation of the characteristics of the pain by questionnaire DN4
Periodo de tiempo: Day 0
One standard DN4 with four questions and ten pain characteristics which gave a score from zero to ten points. If DN4 equal or superior of four out of ten the patient seems possible to develop neuropathic pain.
Day 0
hyperalgesia on surgical site using a brush and Von Frey Filament
Periodo de tiempo: Day 0
The measure is a binary measure (positive or negative)
Day 0
Evaluation of the characteristics of the pain by questionnaire Neuropathic Pain Symptom Inventory (NPSI)
Periodo de tiempo: Day 0
Twelve questions with a score from zero to ten, zero stands for no pain and ten maximal pain scale. A score is given for burning pain (score out of ten), constriction pain (score out of ten), paroxystic pain (score out of ten), evoked pain (score out of ten), paresthesia (score out of ten) and a total score (out of one hundred)
Day 0
Evaluation of the characteristics of the pain by questionnaire Brief Pain Inventory
Periodo de tiempo: Day 0
Fifteen questions compose the questionnaire, the first one is a binary answer yes or no, the second one is a schema to localize the pain, thirteen following questions are scaled with a score from zero to ten, zero stands for no pain and ten maximal pain scale
Day 0

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Questionnaire EORTC QLQC30 to assess Quality of life of cancer patients
Periodo de tiempo: day 0
a score is given for each question, Thirty questions with for each question a score from one (not at all), two (a bit), three (enough) to four (a lot). Two last questions are scale from one (really bad) to seven (excellent)
day 0
Questionnaire EORTC QLQ-H&N35 to assess Quality of life of head and neck cancer patient
Periodo de tiempo: day 0
a score is given for 34 questions (with for each question a score from one (not at all), two (a bit), three (enough) to four (a lot)), for the last 5 questions there is a binary scale (1 for no answer and 2 for yes).
day 0
Quality of life evaluate by the Questionnaire EORTC QLQ-H&N35
Periodo de tiempo: Day 0
a score is given for 34 questions (with for each question a score from one (not at all), two (a bit), three (enough) to four (a lot)), for the last 5 questions there is a binary scale (1 for no answer and 2 for yes)
Day 0
Pain Catastrophizing Scale (PCS-CF) to assess the catastrophizing
Periodo de tiempo: Day 0

thirteen questions with for each question a score from zero (not at all), one (a bit), two (moderatly), three (a lot) to four (constantly).

A score inferior than thirty mark a moderate risk to develop chronic pain. A score superior than thirty mark a high risk to develop chronic pain.

Day 0
Anxious and depression disorder screening using questionnaire Hospital Anxiety and Depression scale (HAD)
Periodo de tiempo: day 0
Fourteen items scaled from zero to three, seven questions refer to anxiety seven others to depressive dimension Both of them gathered to make a score of twenty-one for maximum
day 0

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Nathalie PHAM DANG, University Hospital, Clermont-Ferrand

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

31 de julio de 2020

Finalización primaria (Anticipado)

1 de julio de 2025

Finalización del estudio (Anticipado)

1 de julio de 2025

Fechas de registro del estudio

Enviado por primera vez

10 de septiembre de 2020

Primero enviado que cumplió con los criterios de control de calidad

14 de diciembre de 2020

Publicado por primera vez (Actual)

17 de diciembre de 2020

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de diciembre de 2020

Última actualización enviada que cumplió con los criterios de control de calidad

14 de diciembre de 2020

Última verificación

1 de septiembre de 2020

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre diagnostic tes for neuropathic pain

3
Suscribir